Evidence map›Paper›PMID 40626807›Full record

ArticleInvestigative ophthalmology & visual science2025

In Vivo Characterization of Bruch's Membrane Breaks in Neovascular Age-Related Macular Degeneration Using High-Resolution Optical Coherence Tomography.

Mai Alhelaly, Ceren Soylu, Giulia Corradetti, Federico Corvi, Alireza Mahmoudi, Rouzbeh Abbasgholizadeh, Giovanni Bellisario, Ye He, Alberto Quarta, Muneeswar G Nittala and 2 more

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Ranibizumab port delivery system for neovascular age-related macular degeneration: Current evidence and surgical considerations.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Review
  2. Article
  3. Global choroidal thickness in healthy eyes assessed by ultra-widefield swept-source optical coherence tomography.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mai AlhelalyDoheny Eye Institute, Pasadena, California, United States.
Ceren SoyluDoheny Eye Institute, Pasadena, California, United States.
Giulia CorradettiDoheny Eye Institute, Pasadena, California, United States.
Federico CorviEye Clinic, Department of Biomedical and Clinical Science "Luigi Sacco," Sacco Hospital, University of Milan, Milan, Italy.
Alireza MahmoudiDoheny Eye Institute, Pasadena, California, United States.
Rouzbeh AbbasgholizadehDoheny Eye Institute, Pasadena, California, United States.
Giovanni BellisarioDoheny Eye Institute, Pasadena, California, United States.
Ye HeDoheny Eye Institute, Pasadena, California, United States.
Alberto QuartaDoheny Eye Institute, Pasadena, California, United States.
Muneeswar G NittalaDoheny Eye Institute, Pasadena, California, United States.
Giovanni StaurenghiEye Clinic, Department of Biomedical and Clinical Science "Luigi Sacco," Sacco Hospital, University of Milan, Milan, Italy.
SriniVas R SaddaDoheny Eye Institute, Pasadena, California, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The purpose of this study was to investigate the frequency and characteristics of Bruch's membrane (BM) breaks, and their relationship with clinically relevant outcomes in neovascular age-related macular degeneration (nAMD). Methods: Forty-seven eyes (39 patients) with nAMD and type 1 macular neovascularization (MNV) were imaged using high-resolution optical coherence tomography (High-Res OCT; Heidelberg). Foveal-centered 20 degrees × 20 degrees volume scans (1024 × 97, automated real time [ART] = 5-25) were obtained. BM breaks, defined as definite interruptions in the hyper-reflective BM band, were identified within the MNV region. The maximum break extent was measured. Break density, distribution, and eccentricity were also evaluated. BM break parameters were correlated with visual acuity and number of intravitreal injections. Results: Thirty eyes were included for quantitative analysis. Multiple breaks were observed in 76.7% of eyes, with a mean of 4.30 ± 4.15 breaks/eye. Notably, breaks showed a preferential eccentric distribution, tending to be closer to the lesion border (mean eccentricity ratio = 4.33 ± 3.61). Our model suggested that a higher break count was significantly associated with higher injection number (P = 0.042), whereas a greater break length was associated with fewer injections (P = 0.001). There was a trend for a higher break count to be associated with better BCVA, but this was not statistically significant (P = 0.099). Conclusions: Most MNV lesions demonstrated multiple breaks with a tendency for breaks to be in the lesion periphery. The identification of BM breaks appeared to be of clinical relevance as the number and length of the breaks were associated with the number of intravitreal injections. Larger prospective studies are warranted to confirm these findings.

Indexed as

Bruch MembraneChoroidal NeovascularizationTomography, Optical CoherenceWet Macular DegenerationAgedAged, 80 and overAngiogenesis InhibitorsFemaleFluorescein AngiographyFollow-Up StudiesHumansIntravitreal InjectionsMaleMiddle AgedRetrospective StudiesVisual AcuityAngiogenesis Inhibitors

Identifiers

PMID40626807
PMCPMC12248956

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.